Loading...
Loading...
Browse all stories on DeepNewz
VisitDCGI Approves ENTOD Pharmaceuticals' PresVu Eye Drops to Reduce Dependency on Reading Glasses
Sep 4, 2024, 03:40 AM
The Drug Controller General of India (DCGI) has approved new eye drops developed by ENTOD Pharmaceuticals, designed to reduce the dependency on reading glasses for individuals with presbyopia. The eye drops, named PresVu, have been under deliberation for over two years before receiving final approval. This marks India’s first eye drops aimed at eliminating the need for reading glasses.
View original story
Markets
No • 50%
Yes • 50%
Sales data released by ENTOD Pharmaceuticals or industry reports
No • 50%
Yes • 50%
Official announcements from recognized award organizations
Yes • 50%
No • 50%
Official announcements from regulatory bodies or ENTOD Pharmaceuticals
Less than 10,000 • 25%
More than 30,000 • 25%
20,000 - 30,000 • 25%
10,000 - 20,000 • 25%
Prescription data from healthcare providers or industry reports
10% - 20% • 25%
More than 30% • 25%
Less than 10% • 25%
20% - 30% • 25%
Market analysis reports from reputed market research firms
Other • 25%
Sun Pharma • 25%
Dr. Reddy's Laboratories • 25%
Cipla • 25%
Official announcements from competitors or regulatory bodies